Dengue: A literature review and case study of travelers from the United States, 1986-1994

Journal of Travel Medicine

Volumn 4, Issue 2, 1997, Pages 65-71

  Rigau Pérez, José G ^a   Gubler, Duane J ^b   Vorndam, A Vance ^a   Clark, Gary G ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (Puerto Rico)

^b NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AEDES AEGYPTI; ARTICLE; CLINICAL FEATURE; DENGUE; HUMAN; PATIENT CARE; RISK FACTOR; TRAVEL; UNITED STATES;

EID: 0030788178     PISSN: 11951982     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1708-8305.1997.tb00782.x     Document Type: Article

References (51)

1. Gubler DJ. Dengue in the United States, 1983-1984. In: CDC surveillance summaries. MMWR 1985;34(No. 2SS):5-8.
2. Centers for Disease Control and Prevention (CDC). Imported and indigenous dengue fever - United States, 1986. MMWR 1987;36:551-554.
3. Rigau-Pérez JG, Gubler DJ, Vorndam AV, Clark GG. Dengue surveillance - United States, 1986-1992. In: CDC surveillance summaries, July 22, 1994. MMWR 1994;43(No. SS-2):7-19.
4. CDC. Imported dengue - United States, 1993-1994. MMWR 1995;44:353-356.
5. Institute of Medicine. Emerging infections: microbial threats to health in the United States. Washington, D.C.: National Academy Press, 1992.
6. CDC. Addressing emerging infectious disease threats: a prevention strategy for the United States. Atlanta, Georgia: U.S. Department of Health and Human Services, Public Health Service, 1994.
7. Pan American Health Organization (PAHO). Guidelines for the prevention and control of dengue and dengue hemorrhagic fever in the Americas. Washington, DC: Pan American Health Organization, 1994.
8. World Health Organization. Dengue haemorrhagic fever: diagnosis, treatment, and control. Geneva: World Health Organization, 1986:13.
9. Tassniyom S, Vasanawathana S, Chirawatkul A, Rojanasuphot S. Failure of high-dose methylprednisolone in established dengue shock syndrome: a placebo-controlled, double-blind study. Pediatrics 1993;92:111-115.
10. Sumarmo, Wulur H, Jahja E, et al. Clinical observations on virologically confirmed fatal dengue infections in Jakarta, Indonesia. Bull World Health Organ 1983;61:693-701.
11. Nimmannitya S. Dengue fever/dengue haemorrhagic fever: case management. Trop Med (Nagasaki) 1994;36:249-256.
12. Nimmannitya S, Thisyakorn U, Hemsrichart V. Dengue haemorrhagic fever with unusual manifestations. Southeast Asian J Trop Med Public Health 1987;18:398-406.
13. Martínez Torres E. Dengue y dengue hemorrágico: aspectos clínicos. Salud Pública Mex 37 1995;(Suppl):29-44.
14. Halstead SB. Antibody, macrophages, dengue virus infection, shock, and hemorrhage: a pathogenetic cascade. Rev Infect Dis 1989;11(Suppl 4):S830-839.
15. Morens DM. Antibody-dependent enhancement of infection and the pathogenesis of viral disease. Clin Infect Dis 1994;19: 500-512.
16. Hober D, Poli L, Roblin B, et al. Serum levels of tumor necrosis factor-α (TNFα), interleukin-6 (IL-6), and interleukin-1β (IL-1β) in dengue-infected patients. Am J Trop Med Hyg 1993;48:324-331.
17. Kurane I, Rothman AL, Livingston PG, et al. Immunopathologic mechanisms of dengue hemorrhagic fever and dengue shock syndrome. Arch Virol 1994;9(Suppl):59-64.
18. Kliks SC, Nimmanitya S, Nisalak A, Burke DS. Evidence that maternal dengue antibodies are important in the development of dengue hemorrhagic fever in infants. Am J Trop Med Hyg 1988;38:411-419.
19. Gubler DJ, Reed D, Rosen L, Hitchcock JC Jr. Epidemiologic, clinical, and virologic observations on dengue in the Kingdom of Tonga. Am J Trop Med Hyg 1978;27:581-589.
20. Gubler DJ, Suharyono W, Lubis I, et al. Epidemic dengue 3 in central Java, associated with low viremia in man. Am J Trop Med Hyg 1981;30:1094-1099.
21. Lanciotti RS, Lewis JG, Gubler DJ, Trent DW. Molecular evolution and epidemiology of dengue-3 viruses. J Gen Virol 1993;75:65-75.
22. Thisyakorn U, Nimmanitya S. Nutritional status of children with dengue hemorrhagic fever. Clin Infect Dis 1993;16: 295-297.
23. Bravo JR, Guzmán MG, Kourí GP. Why dengue haemorrhagic fever in Cuba? I. Individual risk factors for dengue haemorrhagic fever/dengue shock syndrome (DHF/DSS).Trans R Soc Trop Med Hyg 1987;81:816-820.
24. Morier L, Kouri-Flores G, Guzmán Tirado G, Soler-Nodarse M. Antibody-dependent enhancement of dengue-2 virus in people of white descent in Cuba. Lancet 1987;1(8540): 1028-1029.
25. Gubler DJ. Dengue haemorrhagic fever: a global update [Editorial]. In: Virus Information Exchange Newsletter. Nedlands, Western Australia: University of Western Australia, 1991;8:2-3.
26. Qiu F-X, Gubler DJ, Liu J-C, Chen Q-Q. Dengue in China: a clinical review. Bull World Health Organ 1993;71:349-359.
27. Halstead SB. The 20th century dengue pandemic: need for surveillance and research. World Health Stat Q 1992;45:292-298.
28. World Health Organization (WHO). Dengue fever/dengue haemorrhagic fever surveillance [Singapore], 1991. Wkly Epidemiol Rec 1992;67:296-297.
29. CDC. Dengue - Texas. MMWR 1980;29:451.
30. CDC. Dengue in the Americas, 1985. MMWR 1986;35: 732-733.
31. CDC. Dengue fever at the U.S.-Mexico border, 1995-1996. MMWR 1996;45:841-844.
32. López Correa RH, Cline BL, Ramírez-Ronda C, et al. Dengue fever with hemorrhagic manifestations: a report of three cases from Puerto Rico. Am J Trop Med Hyg 1978;27: 1216-1224.
33. PAHO. Dengue fever in Costa Rica and Panama. Epidemiol Bull 1994;15:9-10.
34. CDC. Dengue fever among U.S. military personnel - Haiti, September-November, 1994. MMWR 1994;43:845-848.
35. Gubler DJ, Trent DW. Emergence of epidemic dengue/dengue hemorrhagic fever as a public health problem in the Americas. Infect Agents Dis 1994;2:383-393.
36. CDC. Dengue type 3 infection - Nicaragua and Panama, October-November 1994. MMWR 1995;44:21-24.
37. Briseño-García B, Gómez-Dantés H, Argott-Ramírez E, et al. Potential risk for dengue hemorrhagic fever: the isolation of serotype dengue-3 in Mexico. Emerg Infect Dis 1996;2: 133-135.
38. Burke DS, Nisalak A, Ussery MA. Antibody capture immunoassay detection of Japanese encephalitis virus immunoglobulin M and G antibodies in cerebrospinal fluid. J Clin Microbiol 1982;15:1034-1042.
39. Kuno G, Gómez I, Gubler DJ. Detecting artificial anti-dengue IgM immune complexes using an enzyme-linked immunosorbent assay. Am J Trop Med Hyg 1987;36:153-159.
40. Gubler DJ, Sather GE. Laboratory diagnosis of dengue and dengue hemorrhagic fever. In: Fonseca da Cunha F, ed. Simposio Internacional sobre Febre Amarela e Dengue, 1988. Rio de Janeiro: Fundaçao Oswaldo Cruz/Bio-Manguinhos, 1990: 291-322.
41. Clarke DH, Casals J. Techniques for hemagglutination and hemagglutination-inhibition with arthropod-borne viruses. Am J Trop Med Hyg 1958;7:561-573.
42. Chungue E, Marché G, Plichart R, et al. Comparison of immunoglobulin G enzyme-linked immunosorbent assay (IgG-ELISA) and hemagglutination inhibition (HI) test for the detection of dengue antibodies: prevalence of dengue IgG-ELISA antibodies in Tahiti. Trans R Soc Trop Med Hyg 1989;83:708-711.
43. Gubler DJ, Kuno G, Sather GE, et al. Mosquito cell cultures and specific monoclonal antibodies in surveillance for dengue viruses. Am J Trop Med Hyg 1984;33:158-165.
44. Kuno G, Gubler DJ, Vélez M, Oliver A. Comparative sensitivity of three mosquito cell lines for isolation of dengue viruses. Bull World Health Organ 1985;63:279-286.
45. Rosen L, Gubler DJ. The use of mosquitoes to detect and propagate dengue viruses. Am J Trop Med Hyg 1974;23:1153-1160.
46. CDC. Case definitions for public health surveillance. MMWR 1990;39(RR-13):10-11.
47. CDC. Detection of notifiable diseases through surveillance for imported plague - New York, September-October 1994. MMWR 1994;43:805-807.
48. CDC. Summary of notifiable diseases, United States, 1994. MMWR 1994;43(53):70.
49. Gubler DJ. Aedes acgypti and Aedes aegypti-borne disease control in the 1990s: top down or bottom up? Am J Trop Med Hyg 1989;40:571-578.
50. CDC. Advisory memorandum no. 109 - Dengue update. Atlanta: U.S. Department of Health and Human Services, Public Health Service, March 10, 1995.
51. CDC. Biology and control of Aedes aegypti. In: Vector topics no. 4. Atlanta: U.S. Department of Health and Human Services, Public Health Service, CDC, Sept 1979:7,13.